Technical Analysis – GBPJPY proceeds higher after bullish doji



GBPJPY is pushing for another green day, justifying the bullish dragonfly doji candlestick formed on Tuesday following the bounce on the 4 ½-month low of 148.45 and the 23.6% Fibonacci retracement of the March 2020 – May 2021 upleg.

While the bearish cross between the 20- and 50-day simple moving averages (SMAs) is dashing hopes for a trend improvement in the short-term picture, the soft recovery in the MACD and the upturn in the RSI raise expectations that positive momentum could persist. Yet, some caution is still required as the former has yet to cross above its red signal line and the latter continues to fluctuate below its 50 neutral mark.

Looking for resistance levels, the blue Kijun-sen line at 151.79 and the 20-day SMA at 152.27 may prevent the price from touching the 50-day SMA at 153.67. Higher, a break above the 155.14 barrier would shift the spotlight straight to the 156.03 peak, where any violation may prompt a new bullish round towards the 158.00 mark and the long-term resistance line.

Alternatively, a downside reversal may initially pause around 149.50 before heading again for the 23.6% Fibonacci and the 148.45 low. Slightly beneath, a tougher battle could take place near the long-term ascending trendline drawn from the 2020 bottom and the 200-day SMA currently at 146.90. Should sellers gain more ground, the next rebound could occur around 146.25.

In brief, the technical picture suggests GBPJPY could extend its recovery within the short-term bearish trajectory, with the confirmation likely coming above 152.27.

Latest News

US Open Note – Evergrande ghost haunts markets; euro weaker ahead of German election


Weekly comment – Germany votes as markets digest Evergrande


Technical Analysis – NZDUSD positive impetus fades as 100-MA deters gains



Week Ahead – German elections, China woes, and tons of data

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.